SEC 13F Intelligence

Founders Capital Management / ABBV

Founders Capital Management’s Abbvie Inc Position

Does Founders Capital Management own Abbvie Inc (ABBV)? Yes — 24.7K shares worth $5M (+2.62% of its 13F portfolio) as of Q1 2026, down from 24.8K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
24.7K
% of Portfolio
+2.62%
Quarters Held
27
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $4MQ2 ’19: $3MQ3 ’19: $4MQ4 ’19: $5MQ4 ’19Q1 ’20: $4MQ4 ’20: $5MQ2 ’21: $5MQ3 ’21: $4MQ3 ’21Q4 ’21: $5MQ1 ’22: $5MQ2 ’22: $6MQ3 ’22: $5MQ3 ’22Q4 ’22: $6MQ1 ’23: $6MQ2 ’23: $5MQ3 ’23: $5MQ3 ’23Q4 ’23: $5MQ1 ’24: $6MQ2 ’24: $6MQ3 ’24: $6MQ3 ’24Q4 ’24: $6MQ1 ’25: $5MQ2 ’25: $5MQ3 ’25: $6MQ3 ’25Q4 ’25: $6MQ1 ’26: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202624.7K$5M+2.62%
Q4 202524.8K$6M+2.94%
Q3 202524.9K$6M+3.05%
Q2 202525.2K$5M+2.80%
Q1 202525.3K$5M+3.43%
Q4 202431.5K$6M+3.55%
Q3 202432.6K$6M+3.92%
Q2 202432.9K$6M+3.65%
Q1 202433.5K$6M+4.12%
Q4 202333.8K$5M+3.80%
Q3 202334.1K$5M+3.89%
Q2 202335.6K$5M+3.49%
Q1 202335.6K$6M+4.34%
Q4 202236.0K$6M+4.37%
Q3 202235.9K$5M+3.94%
Q2 202236.2K$6M+4.37%
Q1 202238.5K$5M+3.34%
Q4 202138.5K$5M+3.34%
Q3 202138.8K$4M+2.87%
Q2 202141.8K$5M+3.07%
Q4 202044.2K$5M+3.35%
Q1 202050.1K$4M+3.96%
Q4 201956.0K$5M+3.75%
Q3 201947.0K$4M+2.85%
Q2 201944.1K$3M+2.83%
Q1 201944.2K$4M+3.34%
Q4 201844.0K$4M+4.33%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Founders Capital Management’s full portfolio or all institutional holders of ABBV.